Novo Nordisk Stock Pops as Wegovy Pill Sales Surge

Novo Nordisk stock jumped on Wednesday. Patients want weight loss help, and they like the new pill.

The drugmaker beat Wall Street targets by a mile. Sales of the daily Wegovy pill topped all estimates. The company raised its profit outlook for the year because demand keeps growing.

Many patients prefer a simple pill over a weekly needle shot. That choice opens the door to millions of new customers. Novo now works to make enough medicine to fill every order.

This strong quarter proves the weight loss market continues to grow. Novo protects its lead in the race to treat obesity.

Source: CNBC